Share on StockTwits

Alimera Sciences (NASDAQ:ALIM) major shareholder L.P. Bavp sold 7,400 shares of Alimera Sciences stock on the open market in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $6.27, for a total transaction of $46,398.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Shares of Alimera Sciences (NASDAQ:ALIM) traded up 0.64% during mid-day trading on Friday, hitting $6.29. 112,251 shares of the company’s stock traded hands. Alimera Sciences has a 52 week low of $1.65 and a 52 week high of $8.44. The stock’s 50-day moving average is $5.73 and its 200-day moving average is $6.09. The company’s market cap is $254.3 million.

Alimera Sciences (NASDAQ:ALIM) last announced its earnings results on Thursday, August 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.08. The company had revenue of $2.19 million for the quarter, compared to the consensus estimate of $2.70 million. During the same quarter in the previous year, the company posted ($0.67) earnings per share. The company’s revenue for the quarter was up 1123.5% on a year-over-year basis. Analysts expect that Alimera Sciences will post $-1.19 EPS for the current fiscal year.

Alimera Sciences, Incis a biopharmaceutical company that develops and commercializes prescription ophthalmic pharmaceuticals.

Receive News & Ratings for Alimera Sciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alimera Sciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.